Bulletin of the World Health Organization

Maternal multiple micronutrient supplementation and pregnancy outcomes in developing countries: meta-analysis and meta-regression

Kosuke Kawai, Donna Spiegelman, Anuraj H Shankar & Wafaie W Fawzi

Volume 89, Number 6, June 2011, 402-411B

Table 5. Subgroup analysis and meta-regression for the effect of maternal multiple micronutrient supplements on the risk of small size for gestational age in developing countries

Characteristic No. of trials Pooled RR (95% CI) Univariate meta-regression
P-value for test for heterogeneity by covariate Residual I2 after adjusting for covariate (P-value) Reduction in I2 after adjusting for covariate (%)
Average gestational age at initiation of supplements 0.12 9% (0.35) 81
< 20 weeks 9 0.95 (0.89–1.02)
≥ 20 weeks 6 0.77 (0.65–0.91)
No maternal education 0.22 29% (0.16) 34
< 50% 9 0.84 (0.76–0.92)
≥ 50% 4 0.95 (0.84–1.08)
Iron dose in treatment and control groups 0.86 47% (0.02) 0
Same 7 0.82 (0.70–0.97)
Different 8 0.85 (0.67–1.08)
Maternal underweighta 0.47 34% (0.04) 28
< 20% 11 0.85 (0.78–0.91)
≥ 20% 4 0.96 (0.82–1.14)
Average maternal height 0.21 34% (0.10) 28
< 155 cm 7 0.98 (0.91–1.06)
≥ 155 cm 8 0.80 (0.73–0.89)
Primiparas 0.54 47% (0.02) 0
< 35% 8 0.82 (0.70–0.97)
≥ 35% 7 0.85 (0.79–0.92)

CI, confidence interval; RR, relative risk.

a Body mass index (weight in kg divided by square of height in metres) < 18.5.